z-logo
open-access-imgOpen Access
MP49-02 A STUDY TO EVALUATE THE PROGNOSTIC AND PREDICTIVE UTILITY OF CCP AND HRD ASSAYS AND GENETIC SEQUENCING IN PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER
Author(s) -
Hristos Z. Kaimakliotis,
Michael O. Koch,
Lee-Wei Kao,
Jane Cho,
Richard Bihrle,
Роберто Пили,
Clint Cary,
Timothy A. Masterson,
Costantine Albany,
Richard S. Foster,
Julia Reid,
Kirsten M. Timms,
Liang Cheng,
Steve Stone
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.415
Subject(s) - medicine , bladder cancer , cisplatin , cancer , chemotherapy , oncology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom